»GEMSilk« Genetically Engineered Medical Silk

Motivation and problem definition

© Fraunhofer IME | Daniel Brady
Female (left) and male (right) silk cocoons and pupae.
© Fraunhofer IME | Daniel Brady
Newly hatched silkworm
© Fraunhofer IME | Jennifer Kuhn
Adult silkmoth

Sticking things to the inside of the human body is no easy task. Anyone who has ever tried to attach a plaster to moist skin knows how frustrating it can be. In surgery, doctors often have to reattach tissue or close internal wounds in a moist environment. Sutures and staples are usually used. Although a medical adhesive would be faster, gentler and more conformable, existing adhesives often do not hold well, are toxic to tissue or adhere poorly to moist surfaces. Others are safer, but weak and unreliable. The consequences can be serious - after abdominal surgery, for example, up to one in five patients experience internal leakage at the surgical site. It is therefore clear that better medical adhesives are urgently needed.

Nature may already have the solution. Some animals produce waterproof silk that works like adhesive tape under water. These natural adhesives are strong, harden quickly and adhere excellently to moist surfaces - exactly what surgeons are looking for. The problem is that these insects are small and cannot be bred in significant quantities to harvest their sticky silk. But what if we could enable silk-producing insects to do this?

Project goal and solution approach

© Fraunhofer IME | Daniel Brady
Srinithi Kirubakaran (MSc. student) preparing silkworms for analysis.
© Fraunhofer IME | Daniel Brady
PhD candidate Franziska Lai performing microinjection on silkworm eggs.
© Fraunhofer IME | Daniel Brady
Silkworm larva with a visible silk thread (red arrow) produced from the spinneret.

This is precisely the aim of GEMSilk - Genetically Engineered Medical Silk. Funded by Horizon Europe as part of a Marie Skłodowska-Curie Postdoctoral Fellowship - one of the EU's flagship funding programmes - GEMSilk takes an innovative approach: with the aid of CRISPR/Cas9 the domestic silkworm is genetically modified to produce a new type of silk that serves as a biocompatible medical adhesive. Funded by the Marie Skłodowska-Curie Programme, the project builds on the existing expertise of researcher Dr Daniel Brady, who has previously worked on the genetic modification of silkworms to promote sustainable commercial silk production. Led by Prof Philipp Seib, whose research combines biopolymers and healthcare innovation, the project combines genetic engineering and materials science to develop the next generation of silk adhesives. The project is also supported by PhD student Franziska Lai and MSc student Srinithi Kirubakaran.

Using the principles of bionics - learning from nature to solve human challenges - the team aims to create a sustainable and scalable source of medical adhesives. Biology, biotechnology and materials science are merging to meet a long-standing clinical need.

The goals of GEMSilk go beyond a single medical adhesive. The project creates a platform for bio-inspired materials. With different genetic blueprints, silkworms could spin a wide variety of materials in the future - from surgical adhesives to high-performance fibres and bioactive coatings.

The silkworm also offers a scalable production method. A small breeding facility can produce thousands of cocoons - each with one kilometre of silk thread. The infrastructure for silkworm breeding already exists in many parts of the world. The genetic modifications used in GEMSilk are designed to be easily integrated into this system. The silk glue could therefore be produced in commercial quantities using traditional methods.

The research also contributes to the Fraunhofer IME's mission to promote insects in biotechnology. GEMSilk has led to the development of new microinjection laboratories, gene editing protocols and expanded expertise. These advances strengthen the institute's ability to develop bio-based materials and expand its potential in applied research.

More Informations

 

The GEMSilk Project – Pioneering Medical-Silk Biopolymers

 

 

Are you also interested in this topic? Then please contact us!

If you are interested in a collaboration or a research and development service, please contact us!

 

We will jointly assess your problem and evaluate whether we can address it with our platform and our analysis methods.

 

Dr. Daniel Brady

Group Leader

Fraunhofer Institute for Molecular Biology and Applied Ecology IME
Ohlebergsweg 12
35392 Gießen, Deutschland

Phone 064197219-305

 

Biodiversity research